ConductScience.org, home

Paper1350643

Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.

Visakorpi T and 4 others. J Natl Cancer Inst, 1992. Cited by 313 papers, by iCite.

Cite this record

ConductScience Library. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. Papers, record 1350643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1350643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
313
iCite
Relative citation ratio, by iCite
8.73
iCite
Revised in PubMed
2019-05-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Visakorpi TT
2Kallioniemi OPO P
3Heikkinen AA
4Koivula TT
5Isola JJ

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Genes, p53Major topic
MutationMajor topic
Prostatic NeoplasmsMajor topic
Tumor Suppressor Protein p53Major topic
Aged
Antibodies
DNA, Neoplasm
Flow Cytometry
Follow-Up Studies
Humans
Immunohistochemistry
Male
Nuclear Proteins
Prognosis
Proliferating Cell Nuclear Antigen
Retrospective Studies
Time Factors

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 313 citations.

PMIDTitleJournalYearIn PapersSource
39796175The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.Int J Mol Sci2025https://conductscience.org/library/papers/39796175PubMed
38567478Prognostic significance of tumor suppressor protein p53 in prostate cancer.Tunis Med2024https://conductscience.org/library/papers/38567478PubMed
30321230Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.PLoS One2018https://conductscience.org/library/papers/30321230PubMed
29302046p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer.Prostate Cancer Prostatic Dis2018https://conductscience.org/library/papers/29302046PubMed
26712693Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells.Clin Cancer Res2016https://conductscience.org/library/papers/26712693PubMed
25956431Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.BMC Cancer2015https://conductscience.org/library/papers/25956431PubMed
22292443Tissue biomarkers for prostate cancer radiation therapy.Curr Mol Med2012https://conductscience.org/library/papers/22292443PubMed
21786090p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer.Pathol Oncol Res2012https://conductscience.org/library/papers/21786090PubMed
19470936MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.J Clin Oncol2009https://conductscience.org/library/papers/19470936PubMed
18245535Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy.Clin Cancer Res2008https://conductscience.org/library/papers/18245535PubMed
17689883Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17689883PubMed
17619164p53 antibodies in the serum of patients with prostate cancer.Int Urol Nephrol2008https://conductscience.org/library/papers/17619164PubMed
17334767Molecular staging of prostate cancer in the year 2007.World J Urol2007https://conductscience.org/library/papers/17334767PubMed
16985929The future in advanced prostate cancer: take your partners or is the last dance for me?Rev Urol2004https://conductscience.org/library/papers/16985929PubMed
16254107Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.J Clin Pathol2005https://conductscience.org/library/papers/16254107PubMed
15448811The role of HER2/neu, BCL2, p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma.Sao Paulo Med J2004https://conductscience.org/library/papers/15448811PubMed
14999233Molecular biology of prostate cancer.Prostate Cancer Prostatic Dis2004https://conductscience.org/library/papers/14999233PubMed
14663467p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.Prostate Cancer Prostatic Dis2003https://conductscience.org/library/papers/14663467PubMed
11500787Comparison of positivity frequency of bcl-2 expression in prostate adenocarcinoma with low and high Gleason score.Sao Paulo Med J2001https://conductscience.org/library/papers/11500787PubMed
11173606Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).Pathol Oncol Res1996https://conductscience.org/library/papers/11173606PubMed

See all 53 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PCNA5111PubTator's text mininghttps://conductscience.org/library/genes/5111NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1350643

GET https://conductscience.org/api/papers/v1/1350643/cited_by?page=2